Perioperative Nivolumab in Resectable Lung Cancer
2024 · New England Journal of Medicine · 356 citations
https://doi.org/10.1056/nejmoa2311926
Y
Yang Gao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
229
Papers
6.3K
Citations
43
h-index
101
i10-index
Yang Gao is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Protein Degradation and Inhibitors & Ubiquitin and proteasome pathways & Cancer-related molecular mechanisms research. The author has an h-index of 43, co-authored 195 publications.
ORCID: 0000-0002-0518-5249Papers by this author
worksCDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation
2019 · Nature Communications · 257 citations
https://doi.org/10.1038/s41467-019-09703-y
Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade
2021 · Molecular Cell · 236 citations
https://doi.org/10.1016/j.molcel.2021.03.037
RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
2017 · Cell Death and Disease · 57 citations
https://doi.org/10.1038/cddis.2017.9
Glutamate carboxypeptidase II gene knockout attenuates oxidative stress and cortical apoptosis after traumatic brain injury
2016 · BMC Neuroscience · 48 citations
https://doi.org/10.1186/s12868-016-0251-1
Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction
2018 · Cancer Letters · 42 citations
https://doi.org/10.1016/j.canlet.2018.06.012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat